Abstract:Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by immune dysregulation. The global rise in the incidence of both AD and cancer suggests a potential link through shared immune-inflammatory pathways.
Objective: This study aimed to investigate the causal relationship between AD and multiple cancer types and to explore potential underlying biological mechanisms.
Methods: A two-sample Mendelian randomization (MR) analysis was conducted using data from a genome-wide association study of 6,224 AD patients. Seventeen cancer types were assessed. Additionally, expression quantitative trait loci analysis, pathway enrichment, and survival analyses were performed.
Results: MR analysis identified a significant causal relationship between AD and the risk of esophageal cancer (odds ratio [OR] = 0.88, P = 0.0247) as well as colorectal cancer (OR = 0.94, P = 0.0154). Subsequent research revealed differential expression between tumor and normal tissues, with pathway enrichment highlighting immune processes. No survival association was found in esophageal cancer, but MFN2 and SIPA1 expression levels could affect outcomes in colorectal cancer.
Conclusion: This study provides evidence for a protective causal relationship between AD and the risks of esophageal and colorectal cancers. Immune and inflammatory pathways may mediate this link.
Get full access to this article
View all access options for this article.
References
1.
AsherMI, MontefortS, BjörksténB, et al.Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet (London, England). 2006; 368(9537):733–743; doi: 10.1016/s0140-6736(06)69283-0
2.
LaughterMR, MaymoneMBC, MashayekhiS, et al.The global burden of atopic dermatitis: Lessons from the Global Burden of Disease Study 1990–2017. * Br J Dermatol. 2021; 184(2):304–309; doi: 10.1111/bjd.19580
3.
MalikK, HeitmillerKD, CzarnowickiT. An Update on the Pathophysiology of Atopic Dermatitis. Dermatol Clin. 2017; 35(3):317–326; doi: 10.1016/j.det.2017.02.006
4.
RutterCE, SilverwoodRJ, WilliamsHC, et al.; ISAAC Phase Three Study Group. Are environmental factors for atopic Eczema in ISAAC phase three due to reverse causation? J Invest Dermatol. 2019; 139(5):1023–1036; doi: 10.1016/j.jid.2018.08.035
5.
SchulerC, BilliAC, MaverakisE, et al.Novel insights into atopic dermatitis. J Allergy Clin Immunol. 2023; 151(5):1145–1154; doi: 10.1016/j.jaci.2022.10.023
6.
BrayF, LaversanneM, SungH, et al.Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3):229–263; doi: 10.3322/caac.21834
7.
DunnGP, BruceAT, IkedaH, et al.Cancer immunoediting: From immunosurveillance to tumor escape. Nat Immunol. 2002; 3(11):991–998; doi: 10.1038/ni1102-991
8.
ElinavE, NowarskiR, ThaissCA, et al.Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013; 13(11):759–771; doi: 10.1038/nrc3611
9.
KimJA, ParkSJ, ChoiS, et al.Association of the presence of allergic disease with subsequent risk of liver cancer in a nationwide retrospective cohort among Koreans. Sci Rep. 2022; 12(1):9856; doi: 10.1038/s41598-022-14147-4
10.
JoS, KimTJ, LeeH, et al.Associations between atopic dermatitis and risk of gastric cancer: A nationwide population-based study. Korean J Gastroenterol. 2018; 71(1):38–44; doi: 10.4166/kjg.2018.71.1.38
11.
BurgessS, ButterworthA, ThompsonSG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7):658–665; doi: 10.1002/gepi.21758
12.
Davey SmithG, HemaniG. Mendelian randomization: Genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014; 23(R1):R89–R98; doi: 10.1093/hmg/ddu328
13.
SmithGD, EbrahimS. ‘Mendelian randomization’: Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003; 32(1):1–22; doi: 10.1093/ije/dyg070
14.
HemaniG, BowdenJ, Davey SmithG. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018; 27(R2):R195–R208; doi: 10.1093/hmg/ddy163
15.
ElsworthB, LyonM, AlexanderT, et al.The MRC IEU OpenGWAS data infrastructure. bioRxiv. 2020; doi: 10.1101/2020.08.10.2442932020.08.10.244293
16.
GoldmanMJ, CraftB, HastieM, et al.Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020; 38(6):675–678; doi: 10.1038/s41587-020-0546-8
17.
ZhouY, ZhouB, PacheL, et al.Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019; 10(1):1523; doi: 10.1038/s41467-019-09234-6
18.
TangZ, KangB, LiC, et al.GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019; 47(W1):W556–W560; doi: 10.1093/nar/gkz430
19.
Sroka-TomaszewskaJ, TrzeciakM. Molecular mechanisms of atopic dermatitis pathogenesis. Int J Mol Sci. 2021; 22(8):4130; doi: 10.3390/ijms22084130
20.
PallerA, JaworskiJC, SimpsonEL, et al.Major comorbidities of atopic dermatitis: Beyond allergic disorders. Am J Clin Dermatol. 2018; 19(6):821–838; doi: 10.1007/s40257-018-0383-4
21.
SilverbergJI. Comorbidities and the impact of atopic dermatitis. Annals of Allergy, Asthma & Immunology. 2019/08/01. /2019; 123(2):144–151; doi: 10.1016/j.anai.2019.04.020
22.
SilverbergJI, GelfandJM, MargolisDJ, et al.Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults. Annals of Allergy, Asthma & Immunology. 2018/11/01. /2018; 121(5):604–612.e3; doi: 10.1016/j.anai.2018.07.042
23.
EbboM, CrinierA, VélyF, et al.Innate lymphoid cells: Major players in inflammatory diseases. Nat Rev Immunol. 2017; 17(11):665–678; doi: 10.1038/nri.2017.86
24.
SchwartzC, MoranT, SaundersSP, et al.Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β. Allergy. 2019; 74(10):1920–1933; doi: 10.1111/all.13801
25.
BasuA, RamamoorthiG, AlbertG, et al.Differentiation and regulation of T(H) Cells: A balancing act for cancer immunotherapy. Front Immunol. 2021; 12:669474; doi: 10.3389/fimmu.2021.669474
26.
ZhuX, ZhuJ. CD4 T helper cell subsets and related human immunological disorders. Int J Mol Sci. 2020; 21(21):8011; doi: 10.3390/ijms21218011
27.
CoffeltSB, KerstenK, DoornebalCW, et al.IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature. 2015; 522(7556):345–348; doi: 10.1038/nature14282
28.
FormentiniA, BraunP, FrickeH, et al.Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer. Int J Colorectal Dis. 2012; 27(10):1369–1376; doi: 10.1007/s00384-012-1456-0
29.
WeidingerS, IlligT, BaurechtH, et al.Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol. 2006; 118(1):214–219; doi: 10.1016/j.jaci.2006.05.004
30.
YichengF, XinL, TianY, et al.Association of FLG mutation with tumor mutation load and clinical outcomes in patients with gastric cancer. Front Genet. 2022; 13:808542; doi: 10.3389/fgene.2022.808542
31.
ChenH, ZhaoL, LiuJ, et al.Bioinformatic analyzes of the association between upregulated expression of JUN gene via APOBEC-Induced FLG gene mutation and prognosis of cervical cancer. Front Med (Lausanne). 2022; 9:815450; doi: 10.3389/fmed.2022.815450
32.
ZhangP, AnZ, SunC, et al.FLG gene mutation up-regulates the abnormal tumor immune response and promotes the progression of prostate cancer. Curr Pharm Biotechnol. 2022; 23(14):1658–1670; doi: 10.2174/1389201023666220413092507
33.
LiuY, LiuP, DuanS, et al.CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. Cell Death Differ. 2025; 32(4):745–762; doi: 10.1038/s41418-024-01423-1
34.
YuH, LinL, ZhangZ, et al.Targeting NF-κB pathway for the therapy of diseases: Mechanism and clinical study. Signal Transduct Target Ther. 2020; 5(1):209; doi: 10.1038/s41392-020-00312-6
35.
HoeselB, SchmidJA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013; 12(1):86; doi: 10.1186/1476-4598-12-86
36.
HuberMA, AzoiteiN, BaumannB, et al.NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest. 2004; 114(4):569–581; doi: 10.1172/jci21358
37.
XieTX, XiaZ, ZhangN, et al.Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma. Oncol Rep. 2010; 23(3):725–732.
38.
YoshidaA, YoshidaS, IshibashiT, et al.Suppression of retinal neovascularization by the NF-kappaB inhibitor pyrrolidine dithiocarbamate in mice. Invest Ophthalmol Vis Sci. 1999; 40(7):1624–1629.
39.
WangY, PengY, HaoW, et al.Trillin inhibits MAP3K11/NF-κB/COX-2 signaling pathways through upregulation of miR-145-5p in castration-resistant prostate cancer. iScience. 2025; 28(2):111505; doi: 10.1016/j.isci.2024.111505
40.
LeungTH, ZhangLF, WangJ, et al.Topical hypochlorite ameliorates NF-κB-mediated skin diseases in mice. J Clin Invest. 2013; 123(12):5361–5370; doi: 10.1172/jci70895
41.
KoKI, MerletJJ, DerGarabedianBP, et al.NF-κB perturbation reveals unique immunomodulatory functions in Prx1+ fibroblasts that promote development of atopic dermatitis. Sci Transl Med. 2022; 14(630):eabj0324; doi: 10.1126/scitranslmed.abj0324
42.
BarnabeiL, LaplantineE, MbongoW, et al.NF-κB: At the borders of autoimmunity and inflammation. Front Immunol. 2021; 12:716469.
43.
YangJF, XingX, LuoL, et al.Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8(+) T cell metabolic fitness and function in tumors. Sci Immunol. 2023; 8(87):eabq2424; doi: 10.1126/sciimmunol.abq2424
44.
WangD, JinS, LiuH, et al.Celastrol alleviates atopic dermatitis by regulating Ezrin-mediated mitochondrial fission and fusion. J Cell Mol Med. 2024; 28(14):e18375; doi: 10.1111/jcmm.18375
45.
YaoC, WengJ, FengL, et al.SIPA1 enhances aerobic glycolysis through HIF-2α pathway to promote breast cancer metastasis. Front Cell Dev Biol. 2021; 9:779169; doi: 10.3389/fcell.2021.779169
46.
ZhangY, GongY, HuD, et al.Nuclear SIPA1 activates integrin β1 promoter and promotes invasion of breast cancer cells. Oncogene. 2015; 34(11):1451–1462; doi: 10.1038/onc.2014.36
47.
JiK, YeL, TomsAM, et al.Expression of signal-induced proliferation-associated gene 1 (SIPA1), a RapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cells. Cancer Genomics Proteomics. 2012; 9(5):321–327.
48.
ShimizuY, HamazakiY, HattoriM, et al.SPA-1 controls the invasion and metastasis of human prostate cancer. Cancer Sci. 2011; 102(4):828–836; doi: 10.1111/j.1349-7006.2011.01876.x
49.
TsygankovaOM, MaC, TangW, et al.Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion. Mol Cell Biol. 2010; 30(13):3262–3274; doi: 10.1128/mcb.01345-09
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
